Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06090643 · ClinicalTrials.gov registry record · NA
Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups
A NA study of Colorectal Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 9,745
- Enrollment target
- 1
- Study location
NCT06090643 is a NA study of Colorectal Carcinoma that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 9,745 participants, above the 912-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (969% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06090643, a NA study of Colorectal Carcinoma, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 9,745 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial implements research strategies to increase colorectal cancer (CRC) screening rates among low income and ethnic minority groups. CRC is the second most common cause of cancer mortality in the United States and disproportionately burdens low income and ethnic minority groups. Fecal immunochemical testing (FIT) is a test to check for blood in the stool. A brush is used to collect water drops from around the surface of a stool while it is still in the toilet bowl. The samples are then sent to a laboratory, where they are checked for a human blood protein. Blood in the stool may be a sign of colorectal cancer. Despite its potential for reducing CRC incidence and mortality, screening remains woefully underutilized. There is an unmet need for practical and effective programs to improve CRC screening rates. By implementing a culturally-tailored screening CRC program that supports providers and clinic staff to encourage eligible patients to complete FIT, researchers hope to reduce cancer disparities among low-income and ethnic groups and increase the CRC screening rate, which will help providers find CRC sooner, when it may be easier to treat.
Conditions Studied
Interventions
- OTHER Best Practice
- OTHER Educational Intervention
- OTHER Electronic Health Record Review
- OTHER Fecal Immunochemical Test
- OTHER Consultation
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,745 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06090643
The ClinicalTrials.gov registry entry for NCT06090643 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 9,745 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 912-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (969% higher). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Best Practice is the first listed.
NCT06090643 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06090643 about?
NCT06090643 is a clinical study titled "Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups". This clinical trial implements research strategies to increase colorectal cancer (CRC) screening rates among low income and ethnic minority groups. CRC is the second most common cause of cancer mortality in the United States and disproportionately burdens low income and ethnic minority groups. Fecal...
What is the current status of trial NCT06090643?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 9,745 participants. The study started on 2019-11-01. Estimated completion is 2027-11-01.
What conditions does trial NCT06090643 study?
This clinical trial studies the following conditions: Colorectal Carcinoma.
What interventions are being tested in trial NCT06090643?
The interventions under investigation include: Best Practice (OTHER), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Fecal Immunochemical Test (OTHER), Consultation (OTHER).
Who is sponsoring clinical trial NCT06090643?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06090643 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Confronting Cancer as a Community
RECRUITING · NA
-
CoGENES Randomized Controlled Trial (RCT)
RECRUITING · NA
-
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
RECRUITING · NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
RECRUITING · NA
-
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.